Haywood Nathan, Mehaffey J Hunter, Hawkins Robert B, Zhang Aimee, Kron Irving L, Kern John A, Ailawadi Gorav, Teman Nicholas R, Yarboro Leora T
Division of Thoracic & Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia.
Division of Thoracic & Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia; Department of Surgery, University of Arizona - Tucson, Tucson, Arizona.
J Surg Res. 2020 Oct;254:306-313. doi: 10.1016/j.jss.2020.02.019. Epub 2020 Jun 5.
Gastrointestinal complications after cardiac surgery are associated with high morbidity and mortality. We sought to determine the granular impact of individual gastrointestinal complications after cardiac surgery and assess contemporary outcomes.
Patients undergoing cardiac surgery from 2010 to 2017 (6070 patients) were identified from an institutional Society of Thoracic Surgeons database. Records were paired with institutional data assessing gastrointestinal complications and cost. Patients were stratified by early (2010-2013) and current (2014-2017) eras.
A total of 280 (4.6%) patients experienced gastrointestinal complications including Clostridiumdifficile infection (94, 33.6%), gastrointestinal bleed (86, 30.7%), hepatic failure (66, 23.6%), prolonged ileus (59, 21.1%), mesenteric ischemia (47, 16.8%), acute cholecystitis (17, 6.0%), and pancreatitis (14, 5.0%). Gastrointestinal complications were associated with higher rates of early postoperative major morbidity [206 (73.6%) versus 773 (13.4%), P < 0.0001], mortality [78 (27.9%) versus 161 (2.8%), P < 0.0001], length of stay (23 versus 6 d, P < 0.0001), and discharge to a facility [115 (41.1%) versus 1395 (24.1%), P < 0.0001]. Patients suffering gastrointestinal complications had worse risk-adjusted long-term survival (hazard ratio: 3.0, P < 0.0001) and higher adjusted cost ($9,173, P = 0.05). Between eras, there was no difference in incidence of gastrointestinal complications [139 (4.4%) versus 141 (4.8%), P = 0.51] or rate of specific complications (all P > 0.05). However, long-term survival increased in modern era (P < 0.0001).
Although incidence of gastrointestinal complications after cardiac surgery has not changed over time, long-term survival has improved. Gastrointestinal complications remain associated with high resource utilization and major morbidity, but patients are now more likely to recover, highlighting the benefit of quality improvement efforts.
心脏手术后的胃肠道并发症与高发病率和死亡率相关。我们试图确定心脏手术后个体胃肠道并发症的具体影响,并评估当代的治疗结果。
从机构胸外科医师协会数据库中识别出2010年至2017年接受心脏手术的患者(共6070例)。记录与评估胃肠道并发症及费用的机构数据进行配对。患者按早期(2010 - 2013年)和当前(2014 - 2017年)时期进行分层。
共有280例(4.6%)患者发生胃肠道并发症,包括艰难梭菌感染(94例,33.6%)、胃肠道出血(86例,30.7%)、肝衰竭(66例,23.6%)、肠梗阻延长(59例,21.1%)、肠系膜缺血(47例,16.8%)、急性胆囊炎(17例,6.0%)和胰腺炎(14例,5.0%)。胃肠道并发症与术后早期主要并发症发生率较高相关[206例(73.6%)对773例(13.4%),P < 0.0001]、死亡率较高相关[78例(27.9%)对161例(2.8%),P < 0.0001]、住院时间较长相关(23天对6天,P < 0.0001)以及转至其他机构的比例较高相关[115例(41.1%)对1395例(24.1%),P < 0.0001]。发生胃肠道并发症的患者风险调整后的长期生存率较差(风险比:3.0,P < 0.0001)且调整后的费用较高(9173美元,P = 0.05)。在不同时期之间,胃肠道并发症的发生率[139例(4.4%)对141例(4.8%),P = 0.51]或特定并发症的发生率(所有P > 0.05)没有差异。然而,现代时期的长期生存率有所提高(P < 0.0001)。
尽管心脏手术后胃肠道并发症的发生率未随时间变化,但长期生存率有所改善。胃肠道并发症仍然与高资源利用率和主要并发症相关,但患者现在更有可能康复,这突出了质量改进努力的益处。